ABOUT
Interon Laboratories is developing a new category of immunotherapy: neuro-immunotherapy.
Interon's exclusive technology brings together neurobiology and immunology, and is novel and non-invasive. This revolutionary science includes discoveries made by Interon's Co-Founders at MIT and Harvard Medical School, and was featured in journals including Nature, Science and Cell.
Additionally, Interon has two lead programs to develop biologics and small molecule therapeutics for mitigating neurological and immune disorders.